< div> According to peer-reviewed research published in July in Cancer Research, sildenafil—the active ingredient in Viagra—disrupts cancer cells’ cholesterol supply to stop the spread of metastases. Researchers at the Weizmann Institute of Science, alongside teams from the US National Cancer Institute and Clalit Health Services, found that the drug targets the protein transporting essential … Read more
A new blood test, Stockholm3, detected 90% of aggressive prostate cancer cases in clinical trials, outperforming the traditional prostate-specific antigen (PSA) test, which identified 74%. According to a study published in the Annals of Internal Medicine, the test could improve early detection of curable disease while reducing unnecessary biopsies and MRIs for men aged 50 … Read more
Cancer Research UK is increasing its annual investment in the Manchester Biomarker Centre from £11m to £17m to accelerate the development of personalized cancer treatments. The facility, located within the University of Manchester’s Paterson building, will use the funding to integrate artificial intelligence, data science, and immunology into its clinical research, while recruiting 100 additional … Read more
Beyond the Pandemic: The New Frontier of mRNA Medicine The global success of COVID-19 vaccines was merely the opening act. While mRNA technology made household names of companies like Moderna and Pfizer-BioNTech, the true revolution is only just beginning. We are moving from a world where mRNA is synonymous with “vaccine” to one where it … Read more
The Heart’s Secret Defense: How Mechanical Stress Fights Cancer For decades, medical professionals have noted a curious phenomenon: primary heart cancer is exceptionally rare. While most organs in the human body are susceptible to malignant growths, the heart seems to possess a natural resilience. Recent research published in the journal Science has finally provided a … Read more
The Evolution of Early Detection: Why Patient Advocacy is the New Standard For many years, breast cancer screenings were viewed primarily through the lens of age-related risk. While, the journey of young patients like Maddie Squire highlights a critical shift in the medical landscape: the necessity of patient advocacy regardless of age or family history. … Read more
Gotistobart: A Potential Turning Point for Advanced Squamous Lung Cancer? For patients battling metastatic squamous non-small cell lung cancer (sqNSCLC) who have exhausted other treatment options, a new horizon may be emerging. Early results from the PRESERVE-003 trial, published in Nature Medicine, suggest that gotistobart, a novel anti-CTLA-4 antibody, could significantly improve survival rates compared … Read more
The Future of Wartime Healthcare: Teletherapy Corridors and Remote Expertise The convergence of conflict and medical innovation is reshaping healthcare delivery in war zones. A novel model, dubbed ‘Teletherapy Corridors,’ is gaining traction, leveraging remote expertise to provide critical care where it’s needed most. This approach, detailed in a recent Nature Medicine publication (doi:10.1038/s41591-026-04298-6), focuses … Read more
The Future of Cancer Immunotherapy: Beyond Checkpoints The landscape of cancer treatment is rapidly evolving, with immunotherapy taking center stage. While checkpoint inhibitors have revolutionized care for many, a significant portion of patients don’t respond. Researchers are now focusing on expanding the reach of immunotherapy, particularly for cancers with unique challenges like HLA class I … Read more
Rezatapopt: A New Hope for Cancer Patients with TP53 Mutations For decades, the TP53 gene, often called the “guardian of the genome,” has been a central focus in cancer research. Mutations in this gene are found in over 50% of all human cancers. Now, a new therapeutic approach centered around the small molecule rezatapopt is … Read more